Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correction to: Recommendations for the use of biomarkers for head and neck cancer, including salivary gland tumours: a consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
Trigo J, García-Cosío M, García-Castaño A, Gomà M, Mesia-Nin R, Ruiz-Bravo E, Soria-Rivas A, Castillo P, Braña-García I, Alberola-Ferranti M. Trigo J, et al. Among authors: goma m. Clin Transl Oncol. 2023 Jan;25(1):292. doi: 10.1007/s12094-022-02954-0. Clin Transl Oncol. 2023. PMID: 36152138 Free PMC article. No abstract available.
Recommendations for the use of biomarkers for head and neck cancer, including salivary gland tumours: a consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
Trigo J, García-Cosío M, García-Castaño A, Gomà M, Mesia-Nin R, Ruiz-Bravo E, Soria-Rivas A, Castillo P, Braña-García I, Alberola-Ferranti M. Trigo J, et al. Among authors: goma m. Clin Transl Oncol. 2022 Oct;24(10):1890-1902. doi: 10.1007/s12094-022-02856-1. Epub 2022 Jun 23. Clin Transl Oncol. 2022. PMID: 35739348 Free PMC article.
Recommendations for the use of biomarkers for head and neck cancer, including salivary gland tumours: A Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
Pérez JMT, García-Cosío M, García-Castaño A, Gomà M, Mesia-Nin R, Ruiz-Bravo E, Soria-Rivas A, Castillo P, Braña-García I, Alberola-Ferranti M. Pérez JMT, et al. Among authors: goma m. Rev Esp Patol. 2023 Jan-Mar;56(1):45-57. doi: 10.1016/j.patol.2022.06.003. Epub 2022 Aug 27. Rev Esp Patol. 2023. PMID: 36599600 Review.
Nivolumab Plus Ipilimumab for Treatment-Naïve Metastatic Uveal Melanoma: An Open-Label, Multicenter, Phase II Trial by the Spanish Multidisciplinary Melanoma Group (GEM-1402).
Piulats JM, Espinosa E, de la Cruz Merino L, Varela M, Alonso Carrión L, Martín-Algarra S, López Castro R, Curiel T, Rodríguez-Abreu D, Redrado M, Gomà M, Rullán AJ, Calvo González A, Berrocal-Jaime A. Piulats JM, et al. Among authors: goma m. J Clin Oncol. 2021 Feb 20;39(6):586-598. doi: 10.1200/JCO.20.00550. Epub 2021 Jan 8. J Clin Oncol. 2021. PMID: 33417511 Clinical Trial.
Cytogenetical study of a multifocal uveal melanoma.
Filloy A, Caminal JM, Bruzual MC, Varela Mdel M, Gomà M. Filloy A, et al. Among authors: goma m. Semin Ophthalmol. 2014 May;29(3):163-5. doi: 10.3109/08820538.2013.801496. Epub 2013 Jul 19. Semin Ophthalmol. 2014. PMID: 23869977
[Cytogenetic analysis of choroidal melanoma].
Filloy A, Caminal JM, Varela MM, Gomà M, Arias L, Arruga J. Filloy A, et al. Among authors: goma m. Arch Soc Esp Oftalmol. 2014 Jan;89(1):17-21. doi: 10.1016/j.oftal.2013.07.012. Epub 2013 Oct 16. Arch Soc Esp Oftalmol. 2014. PMID: 24269414 Spanish.
83 results